Grand RoundsArchive

Allergy & Immunology

Treatment of allergies, asthma, and immunologic disorders.

21 editions available

View Latest Edition(May 2, 2026)

2026

May 2, 2026Latest
Grand Rounds: Recent allergy/immunology evidence briefs
May 2, 2026|5 articles
April 25, 2026
Asthma and allergy: biomarkers, neuroimmune circuits, and mechanistic targets across airway and skin disease
April 25, 2026|9 articles
April 18, 2026
Type 2 airway disease: biologic remission, upper-airway control, and early-life and environmental modifiers
April 18, 2026|8 articles
April 11, 2026
Precision endotyping, epithelial–microbial crosstalk, and emerging noninvasive biomarkers are reshaping allergy and asthma care
April 11, 2026|10 articles
April 4, 2026
Targeting eosinophilic pathways and tissue remodeling across asthma, HES, CRS, and IgG4‑related disease
April 4, 2026|9 articles
March 28, 2026
Emerging mechanisms in allergic inflammation, immunotherapy, and primary immunodeficiency with implications for allergy–immunology practice
March 28, 2026|8 articles
March 21, 2026
Asthma and Atopic Disease: Controlling Inflammation Today, Positioning for Precision Therapies Tomorrow
March 21, 2026|9 articles
March 14, 2026
From severe asthma control gaps to epithelial-immune crosstalk: emerging targets across the allergic airway continuum
March 14, 2026|9 articles
March 7, 2026
Eosinophilic pathways, immune imbalance, and hidden immunodeficiency: implications for allergy and immunology practice
March 7, 2026|8 articles
February 28, 2026
Early-life immune programming, environment, and adjunctive strategies in asthma and allergic disease
February 28, 2026|9 articles
February 21, 2026
Asthma, airway disease, and allergy in 2026: timing biologics, parsing phenotypes, and confronting environment
February 21, 2026|10 articles
February 14, 2026
Early-life risk, mucosal barrier biology, and emerging interventions across food allergy and airway disease
February 14, 2026|9 articles
February 7, 2026
Allergy & Asthma Grand Rounds: Biologics, Environment, and Emerging Targets Across the Atopic Spectrum
February 7, 2026|8 articles
January 31, 2026
Mechanistic links between environment, mucosal ecosystems, and emerging tolerogenic strategies in allergy and asthma
January 31, 2026|9 articles
January 24, 2026
Asthma risk stratification, biologic use, and emerging immune endotypes across airway and allergic disease
January 24, 2026|9 articles
January 17, 2026
Microbiota, tissue-resident type 2 immunity, and environment: practical levers for allergy and airway disease care
January 17, 2026|9 articles
January 10, 2026
Targeting type 2 inflammation across airways and allergy: mechanisms, risk markers, and real-world treatment effects
January 10, 2026|9 articles

Allergy & Immunology

2026

Grand Rounds: Recent allergy/immunology evidence briefs

Asthma and allergy: biomarkers, neuroimmune circuits, and mechanistic targets across airway and skin disease

Type 2 airway disease: biologic remission, upper-airway control, and early-life and environmental modifiers

Precision endotyping, epithelial–microbial crosstalk, and emerging noninvasive biomarkers are reshaping allergy and asthma care

Targeting eosinophilic pathways and tissue remodeling across asthma, HES, CRS, and IgG4‑related disease

Emerging mechanisms in allergic inflammation, immunotherapy, and primary immunodeficiency with implications for allergy–immunology practice

Asthma and Atopic Disease: Controlling Inflammation Today, Positioning for Precision Therapies Tomorrow

From severe asthma control gaps to epithelial-immune crosstalk: emerging targets across the allergic airway continuum

Eosinophilic pathways, immune imbalance, and hidden immunodeficiency: implications for allergy and immunology practice

Early-life immune programming, environment, and adjunctive strategies in asthma and allergic disease

Asthma, airway disease, and allergy in 2026: timing biologics, parsing phenotypes, and confronting environment

Early-life risk, mucosal barrier biology, and emerging interventions across food allergy and airway disease

Allergy & Asthma Grand Rounds: Biologics, Environment, and Emerging Targets Across the Atopic Spectrum

Mechanistic links between environment, mucosal ecosystems, and emerging tolerogenic strategies in allergy and asthma

Asthma risk stratification, biologic use, and emerging immune endotypes across airway and allergic disease

Microbiota, tissue-resident type 2 immunity, and environment: practical levers for allergy and airway disease care

Targeting type 2 inflammation across airways and allergy: mechanisms, risk markers, and real-world treatment effects

2025

Asthma and Airway Disease: Emerging Targets, Remission Predictors, and Mechanistic Pathways

Allergy & Immunology Grand Rounds: Endotypes, mechanobiology, and immune–microbiome therapeutics

Early-life exposures, immune wiring, and structural change in allergy and asthma

Asthma, Allergy, and Anaphylaxis: From Biomarker-Guided Steroids to Next-Generation Immune Modulation

Allergy & Immunology

2026

Grand Rounds: Recent allergy/immunology evidence briefs

Asthma and allergy: biomarkers, neuroimmune circuits, and mechanistic targets across airway and skin disease

Type 2 airway disease: biologic remission, upper-airway control, and early-life and environmental modifiers

Precision endotyping, epithelial–microbial crosstalk, and emerging noninvasive biomarkers are reshaping allergy and asthma care

Targeting eosinophilic pathways and tissue remodeling across asthma, HES, CRS, and IgG4‑related disease

Emerging mechanisms in allergic inflammation, immunotherapy, and primary immunodeficiency with implications for allergy–immunology practice

Asthma and Atopic Disease: Controlling Inflammation Today, Positioning for Precision Therapies Tomorrow

From severe asthma control gaps to epithelial-immune crosstalk: emerging targets across the allergic airway continuum

Eosinophilic pathways, immune imbalance, and hidden immunodeficiency: implications for allergy and immunology practice

Early-life immune programming, environment, and adjunctive strategies in asthma and allergic disease

Asthma, airway disease, and allergy in 2026: timing biologics, parsing phenotypes, and confronting environment

Early-life risk, mucosal barrier biology, and emerging interventions across food allergy and airway disease

Allergy & Asthma Grand Rounds: Biologics, Environment, and Emerging Targets Across the Atopic Spectrum

Mechanistic links between environment, mucosal ecosystems, and emerging tolerogenic strategies in allergy and asthma

Asthma risk stratification, biologic use, and emerging immune endotypes across airway and allergic disease

Microbiota, tissue-resident type 2 immunity, and environment: practical levers for allergy and airway disease care

Targeting type 2 inflammation across airways and allergy: mechanisms, risk markers, and real-world treatment effects

2025

Asthma and Airway Disease: Emerging Targets, Remission Predictors, and Mechanistic Pathways

Allergy & Immunology Grand Rounds: Endotypes, mechanobiology, and immune–microbiome therapeutics

Early-life exposures, immune wiring, and structural change in allergy and asthma

Asthma, Allergy, and Anaphylaxis: From Biomarker-Guided Steroids to Next-Generation Immune Modulation